Pinned Tweet
We've got some interesting findings on #malaria transmission in Western Kenya @wrair @KEMRI_Kenya @HJFMilMed 👏👏
Malaria Transmission Dynamics in High Transmission Setting of Western Kenya and the Inadequate Treatment Response t… pubmed.ncbi.nlm.nih.gov/3576…
1
Ronnie Raphael retweeted
Let's Talk Micro discusses metallo-β-lactamases and their growing clinical significance.
asm.social/3av
Ronnie Raphael retweeted
The current state of AMR, major challenges in Gram-positive and Gram-negative resistance, the antibiotic pipeline and how the field will move in the next 10 years. asm.social/3at
𝗥𝗲𝘃𝗶𝗲𝘄 𝗔𝗿𝘁𝗶𝗰𝗹𝗲: 𝗣𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝗻𝗴 𝗠𝗮𝗹𝗮𝗿𝗶𝗮 𝗜𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝗻𝘀 𝗮𝗻𝗱 𝗠𝗼𝘃𝗶𝗻𝗴 𝘁𝗼𝘄𝗮𝗿𝗱 𝗠𝗮𝗹𝗮𝗿𝗶𝗮 𝗘𝗹𝗶𝗺𝗶𝗻𝗮𝘁𝗶𝗼𝗻
Malaria continues to be a major health challenge worldwide, causing an estimated 282 million cases of illness and 610,000 deaths in 2024, predominantly among African children. Despite recent stagnation in the progress of malaria prevention, the landscape is undergoing rapid
transformation. A new review examines current and emerging approaches to preventing malaria infection and supporting malaria elimination, including vector control, transmission-blocking interventions, chemoprevention, monoclonal antibodies, and vaccines. Next-generation insecticide-treated nets, expanded use of seasonal malaria chemoprevention, and the introduction of RTS,S/AS01 and R21/Matrix-M vaccines are already reshaping control strategies. Looking ahead, long-acting injectable chemoprevention, transmission-blocking medicines and vaccines, and improved surveillance-driven deployment may further accelerate progress. As funding becomes constrained and decision making shifts increasingly to countries where malaria is endemic, effective malaria prevention will depend on locally tailored, integrated combinations of interventions supported by strong surveillance, regulatory capacity, and national leadership.
Read more about these approaches in the Review Article “Preventing Malaria Infections and Moving toward Malaria Elimination” by Andre Marie Tchouatieu, MD, Timothy N.C. Wells, ScD, and Jane Achan, MD: nej.md/4sQ0qLg

ALT An illustrated diagram from a Review Article titled "Preventing Malaria Infections and Moving toward Malaria Elimination" from the New England Journal of Medicine. The diagram depicts the malaria transmission cycle, showing stages within the mosquito and human bloodstreams. It highlights vector control, vaccination, and other approaches to malaria prevention.
Ronnie Raphael retweeted
Uncovering multidrug-resistance genes and potential biomarkers in Klebsiella pneumoniae using pan-genomic machine-learning feature-selection approach.
Read now in MGen: doi.org/10.1099/mgen.0.00185…
#MGen
Ronnie Raphael retweeted
We are pleased to announce that new lessons have been added to our Tropical Medicine Curriculum, a self-study resource in parasitic and other tropical diseases. New lessons include Fungi 101, Endemic mycoses, Subcutaneous mycoses, Tuberculosis, Hantavirus and Avian Influenza, and Mpox.
🔗 Explore these and all of the Tropical Medicine Curriculum lessons free and open-access on our website. Learn more at parasiteswithoutborders.com/…
Ronnie Raphael retweeted
Successful eradication of Candida auris in a tertiary care ICU following a nearly 30 month outbreak: a drastic “Unit reset” protocol🧐 #IDXposts
cambridge.org/core/journals/…
Ronnie Raphael retweeted
β-Lactam antibiotics and β-lactamases: historical perspectives and a review of β-lactamase inhibitors derived from natural products | Natural Product Reports
pubs.rsc.org/np/article/43/8…
Ronnie Raphael retweeted
The One Health: Antimicrobial Resistance and Emerging Zoonoses Conference (One Health 2027) is March 9-11 in Calgary!
The conference is now accepting abstract submissions for oral and poster presentations. Submit by Dec. 15.
For more info, visit: sparkevents-onehealthamrez.e…
Ronnie Raphael retweeted
FYI, the @CDCgov Antimicrobial Resistance Threats Report provides burden estimates for a list of bacterial & fungal pathogens categorized by level of threat to human health, and a Watch List of pathogens whose burden isn't fully understood.
Learn more: arpsp.cdc.gov/artr
Ronnie Raphael retweeted
High-risk extended-spectrum β-lactamase-producing Klebsiella pneumoniae ST307 in a neonatal sepsis outbreak in Zambia: a secondary genomic analysis.
Available to read in ACMI: doi.org/10.1099/acmi.0.00116…
#AccessMicro
Ronnie Raphael retweeted
Applications for the 2027 In-Country/In-Region Scholarship Programme are OPEN!
Postgraduate opportunities in 8 African countries.
Deadline: 12 November 2026
Final web seminar:
4 November | 2:00–3:30 p.m. EAT
Register: daad-veranstaltung.webex.com…
To the call: daad.de/go/en/stipa10000486
🇰🇪 The Kenya Mini Demographic and Health Survey 2025–26 is out!
Today the Kenya National Bureau of Statistics and the Ministry of Health launched the survey and its data, collected in all 47 counties, from more than 26 000 households.
Key topics include:
✅ Maternal and newborn health
✅ Child health, vaccination and nutrition
✅ Fertility and family planning
✅ Malaria
✅ Water, sanitation and hygiene
✅ Gender-based violence
✅ Health insurance
For the first time, the survey has also measured how children under five are growing, learning and developing, using WHO’s Global Scales for Early Development.
“Today’s launch opens the next stage of this work, putting findings to use,” said @DrNeemaKimambo, WHO Representative to Kenya, speaking on behalf of the UN in Kenya.
Read full report: 🔗 afro.who.int/countries/kenya…
#HealthForAll
#UniversalHealthCoverage
Ronnie Raphael retweeted
Does policy feel far from your day-to-day AMR research? 🧫➡️🏛️
Join AMR in Focus with NextGenAMR to explore how ECRs can navigate science, public engagement & policy.
📅 Mon 23 Nov, 11:30 GMT microb.io/4zj1vgH
#KnockingOutAMR #KOAMR #WAAW2026
📢 Are you an emerging African public health professional? #AFRITRAC offers Master’s fellowships in Biostatistics and Epidemiology to strengthen Africa’s capacity in health data science and epidemic preparedness.
📅 Deadline: Nov 6, 2026
🔗 Apply: buff.ly/I8MDkrD
Ronnie Raphael retweeted
💊🦠Tratamiento antibiótico preferido y alternativo según el mecanismo de resistencia en bacterias gramnegativas
📚 N Engl J Med 2026;395:1728-43.
DOI: 10.1056/NEJMra2506114
Ronnie Raphael retweeted
Are you passionate about public health and looking to expand your knowledge? Apply for the World Health Organisation (WHO) Summer School 2027
The WHO offers an opportunity to deepen your understanding of global health challenges and strengthen your public health knowledge.
Details: opd.to/47LAvec | Deadline: Nov 23
Ronnie Raphael retweeted
Candida auris In 2023:
🔺96% of C. auris samples were resistant to fluconazole
🔺16% of samples were resistant to amphotericin B (a polyene)
🔺Resistance to echinocandins, the recommended first-line treatment, was observed in 1% of samples, but the number of these cases is increasing.
🔺Pan resistance (resistant to all three major classes) has been detected but is rare. #IDXposts
🔥CDC just released the 2026 update to the Antimicrobial Resistance Threats Report (AR Threats Report)🔥
The 2026 update estimates that 19 bacteria and fungi result in 9.7 million infections & 50,800 deaths in the United States each year #IDXposts
arpsp.cdc.gov/artr?ACSTracki…
Ronnie Raphael retweeted
🔺Gram-Negative Bacterial Resistance (NEJM 2026)
nejm.org/doi/full/10.1056/NE…
Ronnie Raphael retweeted
🔥CDC just released the 2026 update to the Antimicrobial Resistance Threats Report (AR Threats Report)🔥
The 2026 update estimates that 19 bacteria and fungi result in 9.7 million infections & 50,800 deaths in the United States each year #IDXposts
arpsp.cdc.gov/artr?ACSTracki…
The spread of gram-negative antimicrobial resistance is driven by human, environmental, and other factors. Pranita D. Tamma, MD, reviews clinically important pathogens, mechanisms driving resistance, and strategies for treatment.
Read the Review Article “Gram-Negative Bacterial Resistance”: nej.md/4yIbmfe

ALT An illustrated diagram from the Review Article "Gram-Negative Bacterial Resistance" that shows a representative gram-negative bacterial cell and the principal mechanisms of antibiotic activity and resistance. Panel A is labeled "Antibiotic Mechanisms against Gram-Negative Bacteria." Panel B is labeled "Gram-Negative Bacteria Resistance Mechanisms against Antibiotics."









































